Iraq: Stabilizing a Growing Market

Ali Mosawi writes for Pharmaceutical Executive on the misconceptions of the country’s often inhospitable landscape, the essential role of international expertise in driving growth and how the sector has adapted to meet the challenges of the COVID-19 pandemic.

Click here to read at Pharmaceutical Executive

Global Dose: Focus on Iraq

Ali Mosawi, Founder of the Al Hayat Scientific Bureau, talks to Pharma Manufacturing.

“There is a vibrancy in the country and our market which I have not seen for some time, driven by the enthusiasm of the young population…”

Click here to continue reading at Pharma Manufacturing 

Lessons from Iraq: preserving safe pharmaceutical distribution in periods of unrest and upheaval

As companies consider the prospect of long-term disruption caused by the coronavirus, Ali Mosawi, chairman of leading Iraqi pharmaceutical
agent Al Hayat, provides an Expert View from 25 years of working in one of the world’s most misunderstood markets.

Click here to continue reading at PharmaLetter

Al Hayat discusses Iraq’s health sector in The National

“The market is very stable, it’s surprising, the business is developing and increasing.”

Al Hayat has reported 35 per cent growth from 2017-2018 and 54 per cent from 2018-2019. In 2017, it won the representation of industry giants Pfizer, Madaus and MSD.

Click here to continue reading at The National.

Founder of the Al Hayat Scientific Bureau Ali Mosawi discusses the path to a safer Iraq

In 1974, my family and I were forced to flee Iraq. We made our new home in the UK, where we found happiness, fairness and opportunity. Even so, as time passed, it became apparent that while I had left Iraq, that country never left me.

Click here to continue reading at Diplomat Magazine.